Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

BACKGROUND: In 2017, Massachusetts General Hospital implemented the Severe Immunotherapy Complications (SIC) Service, a multidisciplinary care team for patients hospitalized with immune-related adverse events (irAEs), a unique spectrum of toxicities associated with immune checkpoint inhibitors (ICIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubiri, Leyre, Molina, Gabriel E, Mooradian, Meghan J, Cohen, Justine, Durbin, Sienna M, Petrillo, Laura, Boland, Genevieve M, Juric, Dejan, Dougan, Michael, Thomas, Molly F, Faje, Alex T, Rengarajan, Michelle, Guidon, Amanda C, Chen, Steven T, Okin, Daniel, Medoff, Benjamin D, Nasrallah, Mazen, Kohler, Minna J, Schoenfeld, Sara R, Leaf, Rebecca K, Sise, Meghan E, Neilan, Tomas G, Zlotoff, Daniel A, Farmer, Jocelyn R, Bardia, Aditya, Sullivan, Ryan J, Blum, Steven M, Semenov, Yevgeniy R, Villani, Alexandra-Chloé, Reynolds, Kerry L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454442/
https://www.ncbi.nlm.nih.gov/pubmed/34544895
http://dx.doi.org/10.1136/jitc-2021-002886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454442/
https://www.ncbi.nlm.nih.gov/pubmed/34544895
http://dx.doi.org/10.1136/jitc-2021-002886

Ejemplares similares